Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a clinical stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease. We have engineered our technologies to activate the immune system's natural ability to create tumor-specific cytotoxic T cells to fight cancer. We are developing multiple product candidates from our two discovery platforms, ZVexTM and GLAASTM, which we believe have the potential to treat a broad patient population either as individual therapies or in combination with other immuno-oncology mechanisms of action. Our primary product candidates, CMB305 and G100, utilize multiple immuno-oncology approaches and, we believe, address the shortcomings of existing therapies. ... More ...
Where does IMDZ fit in the risk graph?
|Annual EPS Est:||$-4.56|
|Quarterly EPS Est:||-0.51|